Systemic Inflammation and Risk of Thromboembolism, Mortality, and Treatment Response in Patients With Cancer Receiving Immune Checkpoint Inhibitors
- DOI
- 10.1111/eci.70243
- Published
- 2026-07-24
- Container
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/eci.70243,
title = {Systemic Inflammation and Risk of Thromboembolism, Mortality, and Treatment Response in Patients With Cancer Receiving Immune Checkpoint Inhibitors},
author = {Leyla Ay and Ingrid Pabinger and Matthias Preusser and Anna Sophie Berghoff and Christoph Hoeller and Cihan Ay and Florian Moik},
year = {2026},
journal = {European Journal of Clinical Investigation},
doi = {10.1111/eci.70243},
url = {https://doi.org/10.1111/eci.70243}
}RIS
TY - JOUR TI - Systemic Inflammation and Risk of Thromboembolism, Mortality, and Treatment Response in Patients With Cancer Receiving Immune Checkpoint Inhibitors AU - Leyla Ay AU - Ingrid Pabinger AU - Matthias Preusser AU - Anna Sophie Berghoff AU - Christoph Hoeller AU - Cihan Ay AU - Florian Moik PY - 2026 JO - European Journal of Clinical Investigation DO - 10.1111/eci.70243 UR - https://doi.org/10.1111/eci.70243 ER -
APA
Ay, L., Pabinger, I., Preusser, M., Berghoff, A. S., Hoeller, C., Ay, C., & Moik, F. (2026). Systemic Inflammation and Risk of Thromboembolism, Mortality, and Treatment Response in Patients With Cancer Receiving Immune Checkpoint Inhibitors. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.70243
Source records
- crossref · retrieved 2026-09-25T09:16:14.650Z